These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 3978316

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit.
    Park BK, Leck JB.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3635-9. PubMed ID: 7181945
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of action of the anticoagulants warfarin, 2-chloro-3-phytylnaphthoquinone (Cl-K), acenocoumarol, brodifacoum and difenacoum in the rabbit [proceedings].
    Breckenridge AM, Leck JB, Park BK, Serlin MJ, Wilson A.
    Br J Pharmacol; 1978 Nov 15; 64(3):399P. PubMed ID: 719257
    [No Abstract] [Full Text] [Related]

  • 4. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing.
    Bruno GR, Howland MA, McMeeking A, Hoffman RS.
    Ann Emerg Med; 2000 Sep 15; 36(3):262-7. PubMed ID: 10969235
    [Abstract] [Full Text] [Related]

  • 5. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats.
    Bachmann KA, Sullivan TJ.
    Pharmacology; 1983 Sep 15; 27(5):281-8. PubMed ID: 6657737
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of eight anticoagulant rodenticides in mice after single oral administration.
    Vandenbroucke V, Bousquet-Melou A, De Backer P, Croubels S.
    J Vet Pharmacol Ther; 2008 Oct 15; 31(5):437-45. PubMed ID: 19000263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
    Trenk D, Möhrke W, Warth L, Jähnchen E.
    Arzneimittelforschung; 1993 Aug 15; 43(8):836-41. PubMed ID: 8216438
    [Abstract] [Full Text] [Related]

  • 13. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H, Ishikawa S, Nomoto S, Nishigaki Y, Ando F, Kashima T, Kimura S, Kanamori M, Echizen H.
    Clin Pharmacol Ther; 2000 Nov 15; 68(5):541-55. PubMed ID: 11103757
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
    Abdelhafez OM, Amin KM, Batran RZ, Maher TJ, Nada SA, Sethumadhavan S.
    Bioorg Med Chem; 2010 May 15; 18(10):3371-8. PubMed ID: 20435480
    [Abstract] [Full Text] [Related]

  • 15. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
    Lilja JJ, Backman JT, Neuvonen PJ.
    Br J Clin Pharmacol; 2005 Apr 15; 59(4):433-9. PubMed ID: 15801938
    [Abstract] [Full Text] [Related]

  • 16. Multi-residue analysis of eight anticoagulant rodenticides in animal plasma and liver using liquid chromatography combined with heated electrospray ionization tandem mass spectrometry.
    Vandenbroucke V, Desmet N, De Backer P, Croubels S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun 15; 869(1-2):101-10. PubMed ID: 18502701
    [Abstract] [Full Text] [Related]

  • 17. Brodifacoum poisoning with toxicokinetic data.
    Olmos V, López CM.
    Clin Toxicol (Phila); 2007 Jun 15; 45(5):487-9. PubMed ID: 17503253
    [Abstract] [Full Text] [Related]

  • 18. Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
    Van Hecken A, Depré M, Verbesselt R, Wynants K, De Lepeleire I, Arnout J, Wong PH, Freeman A, Holland S, Gertz B, De Schepper PJ.
    J Clin Pharmacol; 1999 May 15; 39(5):495-500. PubMed ID: 10234597
    [Abstract] [Full Text] [Related]

  • 19. Covert poisoning with difenacoum: clinical and toxicological observations.
    McCarthy PT, Cox AD, Harrington DJ, Evely RS, Hampton E, al-Sabah AI, Massey E, Jackson H, Ferguson T.
    Hum Exp Toxicol; 1997 Mar 15; 16(3):166-70. PubMed ID: 9088970
    [Abstract] [Full Text] [Related]

  • 20. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins.
    Park BK, Choonara IA, Haynes BP, Breckenridge AM, Malia RG, Preston FE.
    Br J Clin Pharmacol; 1986 Mar 15; 21(3):289-93. PubMed ID: 3964529
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.